Nyrada
Menu
NYR:
Market Cap:
Price Delay ~20min
2020 Interactive Annual Report
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Our Science
Cardiovascular
Neuroprotection
Inflammation/Pain
Autoimmune
Technical Glossary
Publications
Investors
Investor Welcome
ASX Announcements
News
Presentations & Interviews
Share Price Information
Key Dates
Investors Glossary
Corporate Governance
Media
Financial Reports
Annual Reports
Half Yearly Reports
Newsletters
Analyst Reports
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Welcome
ASX Announcements
News
Presentations & Interviews
Share Price Information
Key Dates
Investors Glossary
Corporate Governance
Media
Financial Reports
Annual Reports
Half Yearly Reports
Newsletters
Analyst Reports
ASX Announcements
Filter by Year:
2021
2020
25-Jan-2021
Nyrada Reports Further Results from Cholesterol Study
22-Jan-2021
Unlisted Scientific Advisory Board Options Expiry 15 Feb 21
18-Jan-2021
Change of Director's Interest Notice - ID
18-Jan-2021
Appendix 3G
18-Jan-2021
Appendix 3G
18-Jan-2021
Appendix 3G
7-Jan-2021
Release of Securities from Escrow
6-Jan-2021
Change in substantial holding
21-Dec-2020
57% Cholesterol Reduction from NYX-PCSK9i In Vivo Study
14-Dec-2020
Appointment of New Auditor
1
2
3
4
5
6
7
8
9
Next
